[1] Iqbal M, Yaqub T, Reddy K, McCauley JW. Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 Viruses. PLoS ONE. 2009; 4: 1-18. e5788. doi: 10.1371/journal.pone.00057882.
[2] Iqbal M, Yaqub T, Mukhtar N, Shabbir MZ, McCauley JW. Infectivity and transmissibility of H9N2 avian influenza virus in chickens and wild terrestrial birds. Vet Res 2013; 44: 1-10. doi: 10.1186/1297-9716-44-100.
[3] Guan Y, Shortridge KF., Krauss S, Chin PS, Dyrting KC, Ellis TM, Webster RG, Peiris M. H9N2 influenza Viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol 2000; 74: 9372-9380. doi: 10.1128/JVI.74.20.9372-9380.2000.
[4] Nagy A, Metteleiter TC, Abdelwhab EM. A brief summary of the epidemiology and genetic relatedness of avian influenza H9N2 virus in birds and mammals in the Middle East and North Africa. Epidemiol Infect 2017; 145: 3320-3333. doi:10.1017/S0950268817002576.
[5] Subtain SM, Manzoor S, Khan FM, Hussain Z, Mukhtar M, et al. Study on coinfection of Mycoplasma gallisepticum and low pathogenic avian influenza virus H9 in broilers. J Antivir Antiretrovir 2016; 8: 95-99. doi:10.4172/ jaa.1000142.
[6] Sid H, Hartmann S, Petersen H, Ryll M, Rautenschlein S. Mycoplasma gallisepticum modifies the pathogenesis of influenza A virus in the avian tracheal epithelium. Int J Med Microbiol 2016; 306: 174-186. doi: 10.1016/j.ijmm.2016.04.001.
[7] Barbour EK, Rindala GE, Marc SK, Shaib HA, Danyelle DG, Pia AN. Evaluation of the histopathology of the respiratory system in essential oil-treated broilers following a challenge with Mycoplasma gallisepticum and/or H9N2 Mycoplasma gallisepticum influenza virus. Intern J Appl Res Vet Med 2006; 4: 293-300.
[8] Nili H, Asasi K. Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of Iran. Avian Pathol 2002; 31: 247- 222.
[9] The Center for Food Security and Public Health. 2018. Avian Mycoplasmosis. P. 1-6, Iowa State University, Iowa, USA: 2018.
[10] OIE. World Animal Health Information Database – Version: 1.4. 2018; World Organization for Animal Health, Paris, France: 2009. http://www.oie.int
[11] OIE Handistatus. World Animal Health Publication and Handistatus II, 2005. World Organization for Animal Health, Paris, France. http://www.oie.int
[12] Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368: 1888-1897. doi:10.1056/NEJMoa1304459.
[13] Liu D, Shi W, Shi Y, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 2013; 381: 1926-1932. doi:10.1016/S0140-6736(13)60938-1
[14] Gharaibeh S, Amareen S. Vaccine efficacy against a new avian influenza (H9N2) field isolate from the Middle East (serology and challenge Studies). Avian Diseases 2015; 59: 508-511. https://doi.org/10.1637/11123-050615- Reg.
[15] Umar S, Munir MT, Ur-Rehman Z, Subhan S. Mycoplasmosis in poultry: update on diagnosis and preventive measures. World’s Poult Sci J 2017; 73: 17-28. doi: https://doi.org/10.1017/S0043933916000830.
[16] Sasipreeyajan J, Halvorson DA, Newman JA. Effect of Mycoplasma gallisepticum bacterin on egg-transmission and egg production. Avian Dis 1987; 31:776-781.
[17] Swayne DE. Impact of vaccines and vaccination on global control of avian influenza. Avian Dis 2012; 56: 818-828. https://doi.org/10.1637/10183- 041012-Review.1
[18] Whithear KG, Ghiocas E, Markham PF, Marks D. Examination of Mycoplasma gallisepticum isolates from chickens with respiratory disease in a commercial flock vaccinated with a living M. gallisepticum vaccine. Aust Vet J 1990; 67: 459-460.
[19] Jacob R, Branton SL, Evans JD, Leigh SA, Peebles ED. Effects of live and killed vaccines against Mycoplasma gallisepticum on the performance characteristics of commercial layer chickens. Poult Sci 2014; 93: 1403-1409, https://doi.org/10.3382/ps.2013-03748.
[20] Abd-El-Motelib TY, Kleven SH. A comparative study of Mycoplasma gallisepticum vaccines in young chickens. Avian Dis 1993; 37: 981-987.
[21] Alkie TN, Yitbarek A, Taha-Abdelaziz K, Astill J, Sharif S. Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens. PLoS ONE 2018; 13: e0206324. https://doi.org/10.1371/journal.pone.0206324.
[22] Qin T, Yin Y, Huang L, Yu Q, Yang Q. H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice. Clin Vaccine Immunol 2015; 22: 421-429. doi:10.1128/CVI.00778-14.
[23] Elfaki MG, Kleven SK, Jin LH, Ragland WL. Protection against airsacculitis with sequential systemic and local immunization of chickens using killed Mycoplasma gallisepticum bacterin with iota carrageenan adjuvant. Vaccine 1993; 11: 311-317. https://doi.org/10.1016/0264-410X(93)90192-Z.
[24] Sayed R, Abou-Elhamd K, Abdel-Kader M, Saleem T. Study of surfactant level in cases of primary atrophic rhinitis. J Laryngol Otol 2006; 114: 254-259.
[25] Yarosh D. Topical application of liposomes. J Photochem Photobiol B Biol 1990; 6: 445. doi: 10.1016/1011-1344(90)85118-G.
[26] Homann H, Rosbach O, Moll W, Vogt P, Germann G, Hopp M, Langer- Brauburger B, Reimer K, Steinau H. A liposome hydrogel with polyvinyl- pyrrolidone iodine in the local treatment of partial-thickness burn wounds. Ann Plast Surg 2007; 59: 423. doi: 10.1097/SAP.0b013e3180326fcf.
[27] Reimer K, Vogt P, Broegmann B, Hauser J, Rossbach O, Kramer A, Rudolph P, Bosse B, Schreier H, Fleischer W. An innovative topical drug formulation for wound healing and infection treatment: in vitro and in vivo investigations of a povidone-iodine liposome hydrogel. Dermatology 2000; 201: 235-241. doi: 10.1159/000018494.
[28] Kanmaz T, Karakayali H, Sakallioglu A, Ozdemir B, Haberal M. Polyunsaturated phosphatidylcholine protects against wound contraction in experimental skin burn injury. J Invest Surg 2004; 17: 15-22.
[29] Kornilova Z, Selishcheva A, Perel’man M. Effect of phosphatidylcholine liposome on regeneration of surgical wound in guinea pig lung. Bull Exp Biol Med 2001; 131: 191-194. doi: 10.1023/A:1017564517055
[30] Meyer-Gutknecht H, Mösges R. Wirkungen eines neuartigen liposomalen nasensprays auf die symptome der saisonalen allergischen rhinitis. HNO kompakt Supplement 2008; 1: 1–5.
[31] Li D, Xue M, Wang C, Wang J, Chen P. Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Aavian influenza virus in chickens. Clin Vaccine Immunol 2011; 18:1497-1502. 1556-6811/11/$12.00 doi:10.1128/CVI.05133- 11.
[32] Lu J, Wu P, Zhang X, Feng L, Dong B, Chu X, Liu X, Peng D, Liu Y, Ma H, Jibo Hou J, Tang Y. Immunopotentiators improve the efficacy of oil-emulsion- inactivated avian influenza vaccine in chickens, ducks and geese. PLoS One 2016; 11:e0156573. doi: 10.1371/journal.pone.0156573
[33] Hamad M, Amen O, Mahmoud M, Hassanin O, Saif-Edin M. Effectiveness of different avian influenza (H5) vaccination regimens in layer chickens on the humoral immune response and interferon-alpha signalling immune marker. Vet Res Commun 2018; 42(2):145-152. doi: 10.1007/s11259-018-9717-1. Epub 2018 Apr 4.
[34] Alkie TN, Yitbarek A, Taha-Abdelaziz K, Astill J, Sharif S. Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens. PLoS ONE 2018; 13(11):e0206324. https://doi.org/10.1371/journal.pone.0206324
[35] Huang CM, Lee TT. Immunomodulatory effects of phytogenics in chickens and pigs — A review. Asian-Australas J Anim Sci 2018; 31(5): 617-627. doi: 10.5713/ajas.17.0657
[36] Barbour EK, Newman JA, V. Sivanandan V, Halvorson DA, Sasipreeyajan J. Protection and Immunity in commercial chicken layers administered Mycoplasma gallisepticum liposomal bacterins. Avian Diseases 1987; 31: 723-729.
[37] Barbour EK, Abi Ghanem D, Hamadeh S, Eid A, Talhouk R, Hilan C. Characterization of non-specificity in herbal immunopotentiators of the cell- mediated and humoral immune systems of chickens. AHVMA Journal 1996; 15: 5-7.
[38] Barbour EK, Assi CAA, Shaib H, Hamadeh S, Murtada M, Mahmoud G, Yaghmoor S, Iyer A, Harakeh S, Kumosani T. Evaluation of a Salmonella Enteritidis vaccine and related ELISA for respective induction and assessment of acquired immunity to the vaccine and/or Echinacea purpurea in Awassi ewes. Vaccine. 2015; 33(19): 2228-2231. doi: 10.1016/j.
[39] Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, et al. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol 2002; 2: 381-7.
[40] Gertsch J, Schoop R, Kuenzle U, Suter A. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett 2004; 577: 563-9.
[41] Laasonen M, Wennberg T, Harmia-Pulkkinen T, Vuorela H. Simultaneous analysis of alkamides and caffeic acid derivatives for the identification of Echinacea purpurea Echinacea angustifolia Echinacea pallida and Parthenium integrifolium roots. Planta Med 2002; 68: 572-4.
[42] Zaman M, Chandrudu S, Istvan Toth I. Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res 2013; 3(1): 100-109. doi:10.1007/s13346- 012-0085-z
[43] de Geus ED, Rebel JMJ, Vervelde L. Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines. Vet Quart 2012; 32: 75-86. https://doi.org/10.1080/01652176.2012.711956
[44] Slutter B, Bal S, Keijzer C, Mallants R, Hagenaars N, Que I, Kaijzel E, van Eden W, Augustijns P, PLowik C. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen. Vaccine 2010; 28(38): 6282–6291.
[45] Keijzer C, Slutter B, van der Zee R, Jiskoot W, van Eden W, Broere F. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PLoS One 2011; 6(11): e26684
[46] Ohshima K, Hiramatsu K. Distribution of T-cell subsets and immunoglobulin- containing cells in nasal-associated lymphoid tissue (NALT) of chickens. Histol Histopathol 2000; 15(3): 713-720.
[47] Zakay-Rones Z, Levy R, Spira G. Secretory Newcastle disease virus antibodies from chicken respiratory tract. J Immunol 1972; 109 (2): 311-316.
[48] Parry SH, Aitken ID. Local immunity in the respiratory tract of the chicken. II. The secretory immune response to Newcastle disease virus and the role of IgA. Vet Microbiol 1977; 2: 143-165.
[49] Panigrahy B, Grumbles LC, Hall CF. Immunogenic potency of oil-emulsified Mycoplasma gallisepticum bacterins. Avian Dis 1981; Vol. 25: 821-826. doi: 10.2307/1590055.
[50] Elfaki MG, Kleven SK, Jin LH, Ragland WL. Protection against airsacculitis with sequential systemic and local immunization of chickens using killed Mycoplasma gallisepticum bacterin with iota carrageenan adjuvant. Vaccine 1993; 11: 311-317. https://doi.org/10.1016/0264-410X(93)90192-Z
[51] Yagihashi T, Tajima M, 1986. Antibody Responses in Sera and Respiratory Secretions from Chickens Infected with Mycoplasma gallisepticum. Avian Dis 1986; 30: 543-550. doi: 10.2307/1590419.
[52] Avakian AP, Ley DH. Protective immune response to Mycoplasma gallisepticum demonstrated in respiratory-tract washings from M. gallisepticum-infected chickens. 1993; 37(3): 697-705.
[53] Allen PC. Dietary supplementation with Echinacea and development of immunity to challenge infection with coccidia. Parasitol Res 2003; 91: 74-78.
[54] Barbour EK, El-Hakim RG, Kaadi MS, Shaib HA, Gerges DG, Nehme PA. Evaluation of the histopathology of the respiratory system in essential oil- treated broilers following a challenge with Mycoplasma gallisepticum and/or H9N2 influenza virus. Intern J Appl Res Vet Med 2006; 4: 293-300.
[55] Javed MA, Frasca S Jr, Rood D, Cecchini K, Gladd M, Geary SJ, Silbart LK. 2005. Correlates of immune protection in chickens vaccinated with Mycoplasma gallisepticum strain GT5 following challenge with pathogenic M. gallisepticum strain Rlow. Infect Immun 2005; 73(9): 5410-5419. doi: 10.1128/IAI.73.9.5410-5419.2005
[56] OIE. Infection with Avian Influenza Viruses. Terrestrial Animal Health, Articles– 10.4.33, pp. 1-18. Paris: 2019.
[57] USDA. National Poultry Improvement Plan, United States Department of Agriculture, Animal and Plant Health Inspection Services. Washington D.C.: 2017. http://www.aphis.usda.gov/animal_health/animal_dis_spec/poultry/
[58] Ley DH. Mycoplasma gallisepticum infection in poultry. In: Merck & Co., editors. Merck Manual (Veterinary Manual), Kenilworth, NJ, USA:2019. https://www.merckvetmanual.com › Poultry
[59] Swayne DE. Overview of Avian Influenza. In: Merck & Co., editors. Merck Manual (Veterinary Manual), Kenilworth, NJ, USA: 2019. https://www.merckvetmanual.com › Poultry
[60] Barbour EK, Hamadeh SK, Eid A. Infection and immunity in broiler chicken breeders vaccinated with a temperature sensitive mutant of Mycoplasma gallisepticum and impact on performance of offsprings. Poult Sci 2000; 78: 1730-1735.
[61] Rizwana S, Asim A, Gulbeena S, Ahsan A, Werner K, Kumosani T, Barbour EK. Studies on performance, immunity, and safety of broilers vaccinated with killed H9N2 vaccine and supplemented with essential oils of Mentofin® in drinking water. Intern J Appl Res Vet Med 2017; 15: 67-74.[62] Rodriguez R, Kleven SH. Pathogenicity of two strains of Mycoplasma gallisepticum in broilers. Avian Dis 1980; 24(4): 800-7.
[63] Barbour EK, Newman JA, Sasipreeyajan J, Caputa A, Muneer MA. Identification of the antigenic components of the virulent Mycoplasma gallisepticum (R) in chickens: their role in differentiation from the vaccine strain (F). J Vet Immunol Immunopath 1989; 21: 197-206.
[64] Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965; 13(1) :238-52. doi:10.1016/s0022-2836(65)80093-6
[65] Kuttappan VA, Bielke LR, Wolfenden AD, Berghman LR, Tellez G, Hargis BM, Faulkner OB. Comparison of different ELISA protocols for the detection of IgA against influenza nucleoproteins in trachea of vaccinated chickens. Poult Sci 2015; 94: 181-184. https://doi.org/10.3382/ps/peu054
[66] Barbour EK, Newman JA, Sivanandan V, Sasipreeyajan J. A new biotin- conjugated antisera for quantitation of Mycoplasma gallisepticum immunoglobulin A (IgA) in chicken. Avian Dis 1988; 32: 416-420.
[67] Haiyun J, Wan W, Xueqin Y, Hailong S, Jiawen F, Rui Z, Shifeng W, Huoying S, Xiufan L. Evolution of H9N2 avian influenza virus in embryonated chicken eggs with or without homologous vaccine antibodies. BMC Vet Res 2018; 14: 71. doi: 10.1186/s12917-018-1391-6.
[68] Lin MY, Kleven SH. Improving the Mycoplasma gallisepticum and M. synoviae antigen yield by readjusting the pH of the growth medium to the original alkaline state. Avian Dis 1984; 28: 266-272. doi: 10.2307/1590152.
[69] Ovsyannikova IG, White SJ, Albrecht RA, García-Sastre A, Poland GA. Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against nfluenza A/H1N1. Viral Immunol 2014; 27(4): 174-178. doi: 10.1089/vim.2013.0111.
[70] Nakamura K, Cook JKA, K. Otsuk K, Huggins MB, Frazier JA. Comparative study of respiratory lesions in two chicken lines of different susceptibility infected with infectious bronchitis virus: histology, ultrastructure and immunohistochemistry. Avian Pathol 1991; 20: 241-257.